Aigen Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Aigen Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,524	Closed	-$398K	–	997
2020 Q4	$398K	Sell	5,524 -3,411	-38%	-$179K	0.05%	459
2020 Q3	$407K	Buy	+8,935	New	+$374K	0.05%	447
2020 Q2	–	Sell	-8,622	Closed	-$332K	–	1464
2020 Q1	$332K	Sell	8,622 -8,842	-51%	-$407K	0.04%	561
2019 Q4	$809K	Buy	+17,464	New	+$756K	0.13%	222

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Aigen Investment Management's BEAT Position: Q1 2021 in Review

Aigen Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 5,524 shares — an estimated $398K sold.

Aigen Investment Management first reported a position in BEAT in Q4 2019 and held it in 4 quarters. The position peaked at $809K in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Aigen Investment Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Aigen Investment Management sold 5,524 BioTelemetry, Inc. shares in Q1 2021, an estimated $398K.
Aigen Investment Management first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 4 quarters.
Aigen Investment Management's BioTelemetry, Inc. position peaked at $809K in Q4 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Aigen Investment Management's 13F filing for Q1 2021, filed 11 May 2021.